Tarakji B. Immunohistochemical expression of pRb in pleomorphic ade-noma and carcinoma ex pleomorphic adenoma. Med Oral Patol Oral Cir Bucal. 2011 May 1;16 (3):e323-9.

doi:10.4317/medoral.16.e323

http://dx.doi.org/doi:10.4317/medoral.16.e323

1. Poznic M. Retinoblastoma protein: a central processing unit. J Biosci. 2009;34:305-12.
doi:10.1007/s12038-009-0034-2
PMid:19550046

2. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-30.
doi:10.1016/0092-8674(95)90385-2

3. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006;25:5220-7.
doi:10.1038/sj.onc.1209615
PMid:16936740

4. Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, et al. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res. 1995;55:6200-9.
PMid:8521414

5. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-7.
doi:10.1126/science.274.5293.1672
PMid:8939849

6. Ungari C, Paparo F, Colangeli W, Iannetti G. Parotid glands tumours: overview of a 10-year experience with 282 patients, focusing on 231 benign epithelial neoplasms. Eur Rev Med Pharmacol Sci. 2008;12:321-5.
PMid:19024217

7. Demasi AP, Furuse C, Soares AB, Altemani A, Araújo VC. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Hum Pathol. 2009;40:390-7.
doi:10.1016/j.humpath.2008.06.030
PMid:18992915

8. Suzuki H, Fujioka Y. Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland. Diagn Mol Pathol. 1998;7:224-31.
doi:10.1097/00019606-199808000-00007
PMid:9917133

9. Numata T, Hiruma K, Tsukuda T, Asano T. [Malignant mixed tumor]. Gan To Kagaku Ryoho. 2004;31:314-7.
PMid:15045931

10. Yamamoto Y, Kishimoto Y, Wistuba II, Virmani AK, Vuitch F, Gazdar AF, et al. DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathol Int. 1998;48:265-72.
doi:10.1111/j.1440-1827.1998.tb03904.x
PMid:9648154

11. Nagao K, Matsuzaki O, Saiga H, Sugano I, Shigematsu H, Kaneko T, et al. Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland. Cancer. 1981;48:113-21.
doi:10.1002/1097-0142(19810701)48:1<113::AID-CNCR2820480122>3.0.CO;2-F

12. Chen HH, Lee LY, Chin SC, Chen IH, Liao CT, Huang SF. Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion. World J Surg Oncol. 2010;8:24.
doi:10.1186/1477-7819-8-24
PMid:20353573    PMCid:2860350

13. Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, et al. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands. Anticancer Res. 2000;20:2169-75.
PMid:10928172

14. Etges A, Nunes FD, Ribeiro KC, Araújo VC. Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol. 2004;40:326-31.
doi:10.1016/j.oraloncology.2003.08.021
PMid:14747065

15. Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F, Tannapfel A. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. J Pathol. 2002;198:326-34.
doi:10.1002/path.1210
PMid:12375265

16. Russo G, Zamparelli A, Howard CM, Minimo C, Bellan C, Carillo G, et al. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clin Cancer Res. 2005;11:3265-73.
doi:10.1158/1078-0432.CCR-04-2508
PMid:15867222

17. Zhu Q, Tipoe GL, White FH. Proliferative activity as detected by immunostaining with Ki-67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human parotid gland. Anal Quant Cytol Histol. 1999;21:336-42.
PMid:10560511

18. Liu T, Zhu E, Wang L, Okada T, Yamaguchi A, Okada N. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma. Hum Pathol. 2005;36:962-70.
doi:10.1016/j.humpath.2005.06.014
PMid:16153458

19. Pavelic ZP, Lasmar M, Pavelic L, Sorensen C, Stambrook PJ, Zimmermann N, et al. Absence of retinoblastoma gene product in human primary oral cavity carcinomas. Eur J Cancer B Oral Oncol. 1996;32B:347-51.
doi:10.1016/0964-1955(96)00025-5

20. Do Prado RF, Consolaro A, Taveira LA. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2006;11:E247-51.

21. Tarakji B, Nassani MZ. Immunohistochemical expression of p21 in normal tissues of salivary gland, pleomorphic adenoma and carcinoma ex pleomorphic adenoma-(undifferentiated and adenocarcinoma types). Med Oral Patol Oral Cir Bucal. 2010;15:e697-703.
doi:10.4317/medoral.15.e697

22. Tarakji B, Nassani MZ, Sloan P. Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types. Med Oral Patol Oral Cir Bucal. 2010;15:e432-6.
doi:10.4317/medoral.15.e432